
usd jul pm et
summari major consum product compani market oral person household care well
pet nutrit product countri territori
price-to-earnings oper ep
risk assess reflect view demand
household person care product rel
static sever impact econom cycl
rel industri cl wide geograph
presenc net sale compar
competitor inher expos cl
addit market risk foreign currenc risk
geopolit risk cl sale develop
market remain emerg market
fiscal year end dec ep estim base cfra
oper earn histor earn report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
past perform indic futur perform reli upon
analysi prepar equiti analyst
jul pm stock trade
expect fy sale growth flat
organ sale growth driven
higher price exist product
foreign currenc headwind impact sale
cl net sale
outsid heavili impact
chang foreign currenc rate
expect flat modest gross margin
expans fy heavili reliant
perform back-half
cl work price increas fix inventori
issu china expand roll
new colgat total toothpast hill scienc
diet pet food expect oper margin
contract due increas advertis expens
support new product launch
expect ep fall
rise ep
contract expect attribut
april downgrad recommend
sell hold reflect view
share present balanc risk/reward
trade-off cl share trade histor
peer averag share
high yet cl post peer averag
organ growth margin contract
think due optim new
product launch expect cl
take back market share key develop
market believ mani
oper risk littl room error
risk recommend target price
mainli includ success colgat total
relaunch recent hit retail store
year research anoth risk speed
cl turn around perform
key region china cl work
destock exist inventori build-up
premium product brazil cl
face competit environ
target price
ep estim line
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview colgate-palmol co lead global consum product compani
oper oral person household care pet food market product market
countri territori world-wide
compani oper two product segment oral fy net sale fy
net sale fy net sale pet nutrit fy net sale
compani oral care product includ toothbrush toothpast pharmaceut product oral
health profession cl person care product includ bar liquid soap shampoo condition
deodor antiperspir shave product home care busi produc major brand
palmol ajax soap pet nutrit busi includ specialti pet nutrit product
manufactur market hill pet nutrit
within oral segment fy net sale north america latin america
europ asia pacif africa/eurasia respect
corpor strategi cl seek develop increas market leadership key product categori
geograph expans within exist market categori priorit base
capac maxim use organ core compet strong global equiti
deliv sustain long-term growth oper cl organ along geograph line specif
region manag team respons financi result region manag
focus varieti key indic monitor busi health perform includ market
share sale includ volum price foreign exchang compon gross profit margin oper
profit net incom ep cl also focus measur optim manag work capit
capit expenditur cash flow return capit
compar closest competitor cl greater percentag net sale outsid unit state
fy therefor cl must manag greater risk chang exchang rate
foreign currenc limit imports/export raw materi finish product polit
cl commenc global growth effici program restructur program design
ensur sustain solid world-wide growth unit volum organ sale oper profit earn per
share enhanc global leadership posit core busi fy board approv
expans program extens program fy compani expect annual
save rang million pre-tax million after-tax project
approv implement
impact develop juli cl announc agreement acquir laboratoir
filorga cosmetiqu filorga skin care busi equiti purchas price eur billion
approxim billion deal expect close impact fy ep
filorga premium anti-ag skin care brand focus primarili facial care origin found
franc brand sold countri largest market franc
itali spain greater china filorga brand leverag multi-channel distribut strategi across
pharmaci on-line specialti store travel retail travel retail channel known particularli fast
grow especi region like asia discretionari incom tick higher
trend net sale fy led volum growth price increas
partial off-set neg foreign currenc exchang within oral
product segment sale even fy volum growth price
increas off-set neg foreign exchang net sale hill pet nutrit
increas fy driven volum growth price increas posit foreign
exchang
gross profit margin decreas bp fy fy primarili driven
higher raw packag materi cost bp partial off-set cost save
funding-the-growth initi bp higher price bp
oper margin decreas bp compar fy primarili driven
decreas gross profit bp increas sell gener administr expens
cl increas dividend consecut year one longest streak rel peer
industri cl current offer dividend yield slightli industri averag
yield
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
cl overvalu usd
bullish sinc januari technic indic cl
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
posit fundament outlook
household product sub-industri next
month reflect opportun increas
exposur defens sub-industri
robust dividend yield strong fundament
view stock market current
latter inning bull market
sign feder reserv may start
new rate-cut cycl think
investor move defens stock
strong yet stabl dividend
mean increas incom within household
product see tailwind could
sustain growth momentum next
month includ lower raw materi
transport cost price action
implement late
raw materi use household product
crude oil chemic industri
product fiber notabl
commod price increas price pulp
increas year pulp
core raw materi use napkin paper
towel toilet paper diaper feminin pad
manufactur hand absorb much
higher input cost extend period
time final rais price toward
back half year-to-d
june manufactur complet
near complet target price hike
product also price pulp
anoth tailwind manufactur sinc cost
lower higher price alreadi
implement
freight cost also particularli
higher due strong demand back tight
labor market gave price power
linehaul index track per-mil truckload
linehaul rate independ fuel note
year-over-year increas freight rate
august howev weve sinc
see freight rate eas record high
level may year-over-year
increas freight rate
signifi freight rate still
deceler high rate think due
sever macro factor includ trade
uncertainti lower import china
advers weather condit first
half
household product industri compet
highli competit landscap sever
product offer small larg
compet brand product
well retail privat label brand
compar fast-mov consum
food believ privat label brand present
less threat household good
industri partial due less premium privat
label brand avail marketplac
sign slow consum adopt
think one key factor growth
success industri innov
abil expand geograph presenc
develop market market
satur disruptive-styl
innov tactic identifi consum
trend time effici remain critic
maintain grow market share
year-to-d june
compar broader consum
stapl sector
composit
base index
five-year market price perform jul
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
colgate-palmol compani cl cut target price
ep estim slight discount three-year
forward averag price-to-earnings reflect slow sale earn growth
outlook trim ep estim
cl report oper ep vs line consensu
net sale increas driven growth north america due mostli
recently-acquir profession skin care busi eltamd pca skin
growth partial off-set declin latin america affect
strong currenc headwind declin unit volum gross margin fell
benefit compani cost save initi continu
off-set rise raw packag materi cost expect sale
growth stabl market share level flat price modest volum
cl keep target price
ep estim compar three-year forward averag
price-to-earnings keep ep estim
cl report oper ep vs
consensu sale increas global volum growth flat
price north america remain strong sale growth europ
increas driven mostli currenc tailwind see sale growth
slightli higher price volum growth cl expand
market share across region believ china region remain
challeng increas competit impact brick-and-mortar sale partial
off-set strong e-commerc growth expect modest margin expans
cost save global growth effici program
mostli off-set higher raw materi freight cost /keith snyder
analyst research note compani news
pm et cfra maintain sell opinion share
compani cl cl add high margin person care portfolio
intent acquir premium skin care compani filorga close
impact fy ep aggress strategi view
right one diversifi busi expand margin last year cl
acquir pca skin elta md two skin care brand primarili sold though
profession skin care channel filorga hand sold
mani outlet includ fast-grow travel retail channel one person
care compani cover success travel retail particularli asia
este lauder el recent saw acceler growth china
despit expect slowdown due trade tension yet continu
maintain sell think cl disappoint next quarter given
above-averag valuat below-averag organ growth weaken
think market optimist cl take back share
recent string innov /arun sundaram
pm et cfra lower opinion share compani
sell hold cl lower target price
ep estim line mean lower
ep estim
cl post mar-q ep vs penni
consensu organ sale increas price volum gross
margin fell bp higher input cost downgrad base
imbalanc risk/reward thesi share trade histor peer
averag cl post peer averag organ growth margin
contract although cl plan reignit growth toward back-half
innov price see mani oper risk
warrant premium valuat cl lose market share key develop
market local competit think trend continu given
digit advertis era level play field fragment
market share also high yield /arun
pm et cfra maintain hold rate share
compani cl trim target price base
updat fy ep estim slight discount five-year
forward averag cut ep estim fy
initi fy estim cl report ep
vs ahead consensu organ sale increas
driven strong result pet nutrit segment total sale
organ sale growth gross margin fell bp attribut
higher input cost net sale increas develop market fell
emerg market larg due unfavor fx movement cl
heavili leverag emerg market competitor net
sale north america given cl heavi exposur emerg market
combin strong dollar rise input logist cost
colgate-palmol compani cl keep target
ep estim compar five-year forward
averag price-to-earnings reflect challeng market condit china
latin america cut ep estim
cl report oper ep vs
line consensu sale fell growth north america
driven contribut complet profession skin care
acquisit off-set declin latin america impact
currenc headwind addit latin america volum declin cl
implement price increas number market competitor
result loss market share quarter margin continu
impact inflat cost packag transport trend expect
remain place well project sale growth
price increas gain traction partial off-set addit
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim cl earn
usd quarter fiscal year cl
announc earn per share usd repres
total revenu estim fiscal year
analyst estim cl earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
